SEC Form 4 · accession 0001144204-15-072065

Gramercy Property Trust Inc. · GPT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Charles Laven

Director

Period of report

Dec 17, 2015

Accepted (ET)

Dec 21, 2015 · 9:39 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001287701

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Phantom Stock^F1	$0.00	Dec 17, 2015	D	46,645	D	—	—	Common Stock	46,645	D
Stock Options (Right to Buy)^F2	$85.80	Dec 17, 2015	D	1,350	D	—	Jan 3, 2016	Common Stock	1,350	D
Stock Options (Right to Buy)^F3	$113.60	Dec 17, 2015	D	1,350	D	—	Jan 3, 2017	Common Stock	1,350	D
Stock Options (Right to Buy)^F4	$92.40	Dec 17, 2015	D	1,250	D	—	Jan 3, 2018	Common Stock	1,250	D
Stock Options (Right to Buy)^F5	$5.00	Dec 17, 2015	D	1,250	D	—	Jan 2, 2019	Common Stock	1,250	D
Stock Options (Right to Buy)^F6	$10.92	Dec 17, 2015	D	1,250	D	—	Jan 2, 2020	Common Stock	1,250	D
Stock Options (Right to Buy)^F7	$11.16	Dec 17, 2015	D	1,250	D	—	Jan 2, 2021	Common Stock	1,250	D
Stock Options (Right to Buy)^F8	$10.00	Dec 17, 2015	D	1,250	D	—	Jan 2, 2022	Common Stock	1,250	D
Stock Options (Right to Buy)^F9	$12.20	Dec 17, 2015	D	1,250	D	—	Jan 2, 2023	Common Stock	1,250	D
Stock Options (Right to Buy)^F10	$23.16	Dec 17, 2015	D	1,250	D	—	Jan 2, 2024	Common Stock	1,250	D
Stock Options (Right to Buy)^F11	$24.59	Dec 17, 2015	D	1,250	D	—	Jul 29, 2025	Common Stock	1,250	D

Explanation of responses

F1Disposed of in connection with the merger (the "merger") of issuer with and into a subsidiary of Gramercy Property Trust (formerly known as Chambers Street Properties, "Chambers") and the Director Deferral Plan. The total number of phantom shares listed above reflects a rounding adjustment of one additional share due to administrative error.
F10This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $7.26 per share.
F11This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $7.71 per share.
F2This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 4,306 common shares of beneficial interest of Chambers for $26.90 per share. This grant and all others prior to March 2015 have been adjusted to reflect the 1 for 4 reverse stock split that was completed on March 20, 2015.
F3This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 4,306 common shares of beneficial interest of Chambers for $35.61 per share.
F4This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $28.97 per share.
F5This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $1.57 per share.
F6This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $3.42 per share.
F7This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $3.50 per share.
F8This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $3.13 per share.
F9This option, which was fully vested at the time of the merger, was assumed by Chambers in the merger and replaced with an option to purchase 3,987 common shares of beneficial interest of Chambers for $3.82 per share.